Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 00:00:00 01/08/2026 +04			5-day change	1st Jan Change
83.45 ^USD	+11.95%		+16.65%	+25.73%

07-31	DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							25
	ABBOTT LABORATORIES							24
	MEDTRONIC PLC							25
	CENCORA, INC.							12
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							15
	STERIS PLC							8
	TERUMO CORPORATION							13
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							12
	ALIGN TECHNOLOGY, INC.							14
	INSULET CORPORATION							24
	GLOBUS MEDICAL, INC.							13
	AVANTOR, INC.							14
	DEMANT A/S							20
	Average							17
	Weighted average by Cap.							19